Active surveillance: is there a need for better risk stratification at the outset?

J Clin Oncol. 2010 Oct 1;28(28):e513; author reply e514. doi: 10.1200/JCO.2010.29.3316. Epub 2010 Aug 9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Disease Progression
  • Humans
  • Male
  • Population Surveillance*
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / mortality*
  • Prostatic Neoplasms / surgery
  • Risk Assessment

Substances

  • Prostate-Specific Antigen